ULTRAGENYX PHARMACEUTICAL - MHRA ACCEPTS ULTRAGENYX MAA FOR REBISUFLIGENE ETISPARVOVEC (UX111) ON OCT 28, 2026

Reuters · 3d ago

Please log in to view news